Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

December 1, 2014
Telesta Therapeutics Announces Key Clinical & Corporate Updates

November 25, 2014
BIONICHE LIFE SCIENCES INC. REBRANDS AS TELESTA THERAPEUTICS INC.

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Animal Health

February 2014

26/02/14
Vétoquinol to Acquire the Animal Health Business of Bioniche Life Sciences Inc.

December 2013

02/12/13
Bioniche Life Sciences Inc. Horse Product Approved for Sale in the U.S.

July 2013

15/07/13
Bioniche's Lead Animal Health Product Gains Access to Seven Additional European Markets

May 2013

13/05/13
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business

April 2013

18/04/13
Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in Sweden

March 2013

27/03/13
Bioniche Life Sciences Inc. Receives Government of Canada Support for Second Generation E. coli O157 Vaccine

January 2013

24/01/13
Bioniche Life Sciences Inc. Launches Two New Animal Health Products in Canada

December 2012

13/12/12
Bioniche Life Sciences Inc. Achieves Registration of Enhance™ I.A./I.V. in Hong Kong

04/12/12
Bioniche Life Sciences Inc. Launches NexHA™ in Canada

November 2012

21/11/12
U.S. Distributor Appointed for Bioniche’s ImmunocidinTM Canine Oncology Therapy

October 2012

17/10/12
Bioniche Life Sciences Inc. Announces North American Market Launch of ImmunocidinTM

September 2012

20/09/12
Bioniche Life Sciences Inc. Discovers a Counterfeit Equine Product

August 2012

20/08/12
Bioniche Launches New U.S. Equine Product and Acquires Canadian Distribution Rights to Six Additional Products

13/08/12
Bioniche Life Sciences Inc. Enters into an Exclusive U.S. Distribution Agreement for an Equine Product

07/08/12
Special Treatment Certificate Issued for Importation of E. coli O157 Vaccine into the United Kingdom

July 2012

31/07/12
Bioniche Presents Preliminary Data on the Use of In-Licensed Superagonist Hormone Technology in Cattle

23/07/12
Bioniche Life Sciences Inc. Moves Closer to Market Launch of ImmunocidinTM

May 2012

01/05/12
Bioniche Life Sciences Inc. Commercializing Two Products for Canine Cancer

April 2012

18/04/12
Bioniche Life Sciences Inc. Sponsors Two Major International Livestock Reproduction Conferences

March 2012

23/03/12
Bioniche Life Sciences Inc. Enters into a Distribution Agreement for New Animal Health Products in Australia

December 2011

21/12/11
Bioniche Life Sciences Inc. Enters into Two Distribution Agreements for New Animal Health Products

13/12/11
Bioniche E. coli Vaccine Granted Import Access to Australia

October 2011

27/10/11
Bioniche Life Sciences Inc. Receives Canadian Regulatory Approval for Equine Anti-Inflammatory Product

June 2011

13/06/11
Bioniche Chief Veterinary Scientific Officer Discusses Vaccine Against E. coli O157 at International Meat Industry Conference

May 2011

05/05/11
Econiche™ Vaccine Efficacy Challenge Study Summarized in The Canadian Journal of Veterinary Research

April 2011

29/04/11
Animal Health and Food Safety Vaccine Manufacturing Centre Officially Opens in Belleville, Ontario, Canada

March 2011

22/03/11
Bioniche Life Sciences Inc. Keynote Speaker at 7th Annual NZBIO Conference in New Zealand

November 2010

30/11/10
Bioniche Obtains Exclusive U.S. Rights to Equine Reproductive Product from CreoSalus

15/11/10
Bioniche Presents at U.S. Animal Health Association Committee on Food & Feed Safety

October 2010

18/10/10
Bioniche Scientists Present at Modern Vaccine & Adjuvant Formulation Conference in France

June 2010

23/06/10
Bioniche & Trophogen Sign Exclusive Global Veterinary License Agreement for Superagonist Hormone Technology Platform

02/06/10
Bioniche Animal Health Partners with Bayer Australia to Distribute Livestock Product Line

September 2007

06/09/07
Bioniche Responds to Australian Equine Influenza Outbreak

April 2007

03/04/07
Non-Antibiotic Treatment for Equine Endometritis Study Data Published in International Peer-Reviewed Journal

June 2006

05/06/06
Counterfeit Product Linked to Death of Ontario Horse

03/06/05
New Studies Demonstrate Immunomodulatory Activity of Bioniche Technology in Dogs

May 2005

24/05/05
Bioniche Mycobacterial Cell Wall Extract (MCWE) Granted New Patent for Production Performance in Animals

March 2005

07/03/05
Research Shows Promise for Easy, Effective Management of Sow Breeding

January 2005

21/01/05
Bioniche Receives Authorization to Market Folltropin®-V in Additional EU Countries

December 2004

03/12/04
Livestock Revolution in Global Agriculture

November 2004

29/11/04
New Treatment for Equine Endometritis Given USDA Approval

August 2004

06/08/04
Mycobacterial Cell Wall Formulation Shows Promise in Treating Equine Endometritis

03/08/04
Bomac Laboratories Ltd. to Distribute Bioniche Cue-Mate® Technology in New Zealand

June 2004

21/06/04
Bioniche Commences Sales of Cue-Mate® Animal Reproductive Technology in Australian Cattle Market

18/06/04
Bioniche Receives Approval For New Animal Health Product Indication

10/06/04
Bioniche Presents Positive Data on Anti-Cancer Activity of MCC at 22nd Annual Meeting of American College of Veterinary Internal Medicine

April 2004

19/04/04
Bioniche Acquires Cue-Mate® Reproductive Technology From Pfizer

January 2004

10/01/04
Bioniche Life Sciences and AB Technology Sign Purchase Agreement


Newsroom

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy